WallStreetZenWallStreetZen

NASDAQ: HILS
Hillstream Biopharma Inc Stock

$0.79-0.06 (-7.06%)
Updated Mar 31, 2023
HILS Price
$0.79
Fair Value Price
N/A
Market Cap
$9.12M
52 Week Low
$0.30
52 Week High
$2.65
P/E
-1.06x
P/B
1.64x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$8.47M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.21
Operating Cash Flow
-$7M
Beta
0.85
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

HILS Overview

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapies for treatment resistant cancers. Its approach targets ferroptosis, an anti-cancer mechanism resulting in iron-mediated cancer cell death. Hillstream BioPharma was incorporated in 2017 and is based in Bridgewater, NJ.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how HILS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HILS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HILS is good value based on its book value relative to its share price (1.64x), compared to the US Biotechnology industry average (4.98x)
P/B vs Industry Valuation
HILS is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more HILS due diligence checks available for Premium users.

Be the first to know about important HILS news, forecast changes, insider trades & much more!

HILS News

Valuation

HILS fair value

Fair Value of HILS stock based on Discounted Cash Flow (DCF)
Price
$0.79
Fair Value
$1.88
Undervalued by
57.95%
HILS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HILS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.06x
Industry
18.64x
Market
22.13x

HILS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.64x
Industry
4.98x
HILS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HILS's financial health

Profit margin

Revenue
$0.0
Net Income
-$1.8M
Profit Margin
0%
HILS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$6.7M
Liabilities
$1.1M
Debt to equity
0.21
HILS's short-term assets ($6.69M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HILS's short-term assets ($6.69M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HILS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.1M
Investing
$0.0
Financing
-$22.5k
HILS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

HILS vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
HILS$9.12M-6.82%-1.06x1.64x
VRPX$9.20M-0.63%-0.42x0.55x
PYPD$8.99M+6.24%-0.19x0.47x
ONCR$8.98M+9.21%-0.12x0.15x
CNTX$8.97M-3.44%-0.60x0.26x

Hillstream Biopharma Stock FAQ

What is Hillstream Biopharma's quote symbol?

NASDAQ: HILS) Hillstream Biopharma trades on the NASDAQ under the ticker symbol HILS. Hillstream Biopharma stock quotes can also be displayed as NASDAQ: HILS.

If you're new to stock investing, here's how to buy Hillstream Biopharma stock.

What is the 52 week high and low for Hillstream Biopharma (NASDAQ: HILS)?

(NASDAQ: HILS) Hillstream Biopharma's 52-week high was $2.65, and its 52-week low was $0.30. It is currently -70.11% from its 52-week high and 161.39% from its 52-week low.

How much is Hillstream Biopharma stock worth today?

(NASDAQ: HILS) Hillstream Biopharma currently has 11,514,144 outstanding shares. With Hillstream Biopharma stock trading at $0.79 per share, the total value of Hillstream Biopharma stock (market capitalization) is $9.12M.

Hillstream Biopharma stock was originally listed at a price of $3.48 in Jan 12, 2022. If you had invested in Hillstream Biopharma stock at $3.48, your return over the last 1 years would have been -77.24%, for an annualized return of -77.24% (not including any dividends or dividend reinvestments).

How much is Hillstream Biopharma's stock price per share?

(NASDAQ: HILS) Hillstream Biopharma stock price per share is $0.79 today (as of Mar 31, 2023).

What is Hillstream Biopharma's Market Cap?

(NASDAQ: HILS) Hillstream Biopharma's market cap is $9.12M, as of Apr 2, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Hillstream Biopharma's market cap is calculated by multiplying HILS's current stock price of $0.79 by HILS's total outstanding shares of 11,514,144.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.